Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

22

Revenue 2017

Januvia

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Januvia was produced by Merck & Co..

Intarcia's diabetes implant beats Merck's Januvia in trial

Intarcia's diabetes implant beats Merck's Januvia in trial Merck's Januvia, which achieved global sales of $6bn last year, therefore may face stiff competition in the future as different treatment avenues open up. ... Confidence in Januvia however was recently boosted as concerns about its effect on

Jardiance is first diabetes drug to improve CV outcomes

Jardiance is first diabetes drug to improve CV outcomes At the time, analysts said the warning could peg back growth in the class and boost other diabetes drugs such as the DPP4 inhibitors, led by Merck &Co's $6bn Januvia

Merck hopes for another Keytruda with new immunotherapy deal

Merck hopes for another Keytruda with new immunotherapy deal In the past six months, type II diabetes treatment Januvia (sitagliptin) remains the firm's biggest-selling drug, bringing in $1.92bn, with the combination therapy Janumet adding just over $1bn

Type 2 diabetes market set to hit $39bn by 2021

Type 2 diabetes market set to hit $39bn by 2021 DPP-4 inhibitors are already a widely-used class of drugs, led by Merck &Co's Januvia (sitagliptin), and the class is poised to see newer entrants from the likes of

Novo Nordisk becomes diabetes drug sales leader

Novo Nordisk becomes diabetes drug sales leader All three have consistently been in the top five pharma firms in the therapy area, with Merck's $6bn in sales coming in its entirety from its Januvia(sitagliptin)/Janumet(sitagliptin

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...